These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 4361298)

  • 1. Effects of pH shifts, bile salts, and glucose on sporulation of Clostridium perfringens NCTC 8798.
    Hickey CS; Johnson MG
    Appl Environ Microbiol; 1981 Jan; 41(1):124-9. PubMed ID: 6261681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and antibody responses to Clostridium perfringens type A enterotoxin in experimental sheep and calves.
    Niilo L; Cho HJ
    Can J Comp Med; 1985 Apr; 49(2):145-8. PubMed ID: 4016579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age related variations of serum concentrations of normally occurring IgG antibodies to Clostridium perfringens.
    Zarén E; Schwan A; Frenckner B
    J Clin Pathol; 1987 Mar; 40(3):282-5. PubMed ID: 2881950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid accumulation in mouse ligated intestine inoculated with Clostridium perfringens enterotoxin.
    Yamamoto K; Ohishi I; Sakaguchi G
    Appl Environ Microbiol; 1979 Feb; 37(2):181-6. PubMed ID: 219772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Clostridium perfringens enterotoxin in human fecal samples and anti-enterotoxin in sera.
    Naik HS; Duncan CL
    J Clin Microbiol; 1978 Apr; 7(4):337-40. PubMed ID: 211142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.
    Uzal FA; McClane BA; Cheung JK; Theoret J; Garcia JP; Moore RJ; Rood JI
    Vet Microbiol; 2015 Aug; 179(1-2):23-33. PubMed ID: 25770894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clostridium perfringens enterotoxin].
    Fluer FS
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Jun; (6):19-24. PubMed ID: 197754
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody against Clostridium perfringens type A enterotoxin in human sera.
    Uemura T; Genigeorgis C; Riemann HP; Franti CE
    Infect Immun; 1974 Feb; 9(2):470-1. PubMed ID: 4361298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of Clostridium perfringens enterotoxin antibody in human and animal sera in western Canada.
    Niilo L; Bainborough AR
    Can J Microbiol; 1980 Sep; 26(9):1162-4. PubMed ID: 6257364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of enterotoxigenic Clostridium perfringens type A in mixed cultures.
    Niilo L
    Can J Comp Med; 1979 Jan; 43(1):98-101. PubMed ID: 218711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of sheep against experimental Clostridium perfringens type A enteritis.
    Niilo L; Hauschild AH; Dorward WJ
    Can J Microbiol; 1971 Mar; 17(3):391-5. PubMed ID: 4323916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Method of obtaining an erythrocyte diagnosticum for detecting Cl. perfringens type A enterotoxin].
    Bakulin IN; Kashkina GB; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):79-82. PubMed ID: 6297189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent antibody inhibition for determination of serum antibodies against the enterotoxin of Clostridium perfringens type A.
    Torres-Anjel MJ; Riemann HP
    Rev Latinoam Microbiol; 1974; 16(3):127-9. PubMed ID: 4372662
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animals.
    Finkelstein RA; Peterson JW
    Infect Immun; 1970 Jan; 1(1):21-9. PubMed ID: 16557689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEMAGGLUTINATION STUDIES WITH FORMALINIZED ERYTHROCYTES. EFFECT OF BIS-DIAZO-BENZIDINE AND TANNIC ACID TREATMENT ON SENSITIZATION BY SOLUBLE ANTIGEN.
    BUTLER WT
    J Immunol; 1963 May; 90():663-71. PubMed ID: 14053285
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.